Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response and Durability of HPV Antibodies in Vaccinated Adolescents After Hematopoietic Stem Cell Transplantation
TCTR20240825001Phase 1Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jul 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, single-arm trial of human papillomavirus vaccine in human papillomavirus infection, sponsored by Ramathibodi Hospital. Primary endpoints: HPV antibody levels post-HSCT and Durability of HPV antibodies. Started Jul 2024; status: completed.
02
Drugs
human papillomavirus vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on TCTR20240825001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240825001.